OptionsHouse

Options Trading News

November 7, 2011  Mon 7:26 AM CT

TKLC: SEE CHART GET CHAIN FIND STRATEGIES
Deal Values Tekelec at $780 Million

Tekelec, a maker of networking technology, agreed to be purchased by Siris Capital for $11 a share. TKLC pops 11 percent before the bell.

Pharmasset Lifted by Hep-C Data

Pharmasset released data over the weekend showing promise of its PSI-7977 compound in fighting Hepatitis C. Those results were from a Phase II trial, and now support the case for more advanced Phase III testing. VRUS climbs 9 percent in the premarket.

Omnivision Lowers Outlook

Omnivision Technologies cut its outlook in a preliminary earnings release because of an "unexpected cutback in orders." Management now sees revenue of now more than $217 million, down from an earlier $255-275 million estimate. OVTI drops 17 percent in the pre.
Share this article with your friends


OptionsHouse

Premium Services

Education & Strategy

Market Level Making You Nervous, Huh? Part 3

In last week's article, we discussed how important the extra cash you save by using the Stock Replacement Strategy over buying the actual stock is! That extra cash in our account instead of being unnecessarily tied up in a stock position allows us to buy the puts we would need to protect our downside in the case of a major sell-off.

View more education articles »